LivaNova (LIVN) Receivables - Net (2015 - 2026)
LivaNova (LIVN) posted Receivables - Net of $229.3 million for Q1 2026, up 6.15% sequentially from $216.0 million in Q4 2025, and up 13.46% YoY from $202.1 million in Q1 2025.
LivaNova (LIVN) Receivables - Net (2015 - 2026) Analysis & Trends
LivaNova has reported Receivables - Net for 12 years, with the latest figure at $229.3 million in Q1 2026.
- Quarterly Receivables - Net rose 13.46% year-over-year to $229.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $229.3 million (up 13.46% YoY) and the FY2025 annual result came in at $216.0 million, up 11.82% from the prior year.
- Receivables - Net improved to $229.3 million in Q1 2026 per LIVN's latest filing, from $216.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $229.3 million in Q1 2026 and troughed at $172.1 million in Q3 2022.
- A 5-year average of $197.8 million and a median of $197.2 million in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net gained 17.46% in 2023, then slipped 10.19% in 2024.
- Over 5 years, Receivables - Net stood at $183.1 million in 2022, then grew by 17.46% to $215.1 million in 2023, then decreased by 10.19% to $193.2 million in 2024, then rose by 11.82% to $216.0 million in 2025, then climbed by 6.15% to $229.3 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $229.3 million, $216.0 million, and $211.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 231.30 Mn |
| Jun 30, 2026 | 231.30 Mn |
| Mar 31, 2026 | 229.27 Mn |
| Mar 31, 2026 | 229.27 Mn |
| Dec 31, 2025 | 215.99 Mn |
| Dec 31, 2025 | 215.99 Mn |
| Sep 30, 2025 | 211.58 Mn |
| Sep 30, 2025 | 211.58 Mn |
| Jun 30, 2025 | 220.20 Mn |
| Jun 30, 2025 | 220.20 Mn |
| Mar 31, 2025 | 202.08 Mn |
| Mar 31, 2025 | 202.08 Mn |
| Dec 31, 2024 | 193.16 Mn |
| Dec 31, 2024 | 193.16 Mn |
| Sep 30, 2024 | 197.16 Mn |
| Sep 30, 2024 | 197.16 Mn |
| Jun 30, 2024 | 200.89 Mn |
| Jun 30, 2024 | 200.89 Mn |
| Mar 31, 2024 | 209.43 Mn |
| Mar 31, 2024 | 209.43 Mn |